FLT3 and acute myeloid leukemia: Furthermore, we assessed the prognostic impact of cytogenetics in patients with AML harboring FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD), as it remained unclear whether baseline cytogenetics significantly impacts the post-HSCT outcome in these patients.